{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:28:53Z","timestamp":1792927733795,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.critrevonc.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:18:24Z","timestamp":1495153104000},"page":"58-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas"],"prefix":"10.1016","volume":"116","author":[{"given":"Suja","family":"Pillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred King-Yin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2017.05.005_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1373\/clinchem.2012.194258","article-title":"Circulating tumor cells: liquid biopsy of cancer","volume":"59","author":"Alix-Panabi\u00e8res","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12088-016-0606-4","article-title":"High throughput sequencing: an overview of sequencing chemistry","volume":"56","author":"Ambardar","year":"2016","journal-title":"Indian J. Microbiol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0015","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/gb-2010-11-6-r62","article-title":"Whole exome capture in solution with 3 Gbp of data","volume":"11","author":"Bainbridge","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/14737159.2016.1133298","article-title":"Advances in clinicalnext-generation sequencing: target enrichment and sequencing technologies","volume":"16","author":"Ballester","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"13","key":"10.1016\/j.critrevonc.2017.05.005_bib0025","article-title":"Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma\/paraganglioma patients","volume":"14","author":"Bennedb\u00e6k","year":"2016","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14622416.6.4.373","article-title":"Toward the 1,000 dollars human genome","volume":"6","author":"Bennett","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0035","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-13-3114","article-title":"High-throughput detection ofclinically relevant mutations in archived tumor samples by multiplexed PCR andnext-generation sequencing","volume":"20","author":"Bourgon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-relatedpolycythemia-paraganglioma syndrome","volume":"99","author":"Buffet","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CCO.0000000000000249","article-title":"Pheochromocytoma and paraganglioma: molecular testing and personalized medicine","volume":"28","author":"Burnichon","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.gene.2013.04.081","article-title":"Analysis of the inheritance pattern of a Chinese family with phaeochromocytomas through whole exome sequencing","volume":"526","author":"Cao","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1210\/jc.2013-4536","article-title":"Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation","volume":"99","author":"Casey","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0065","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0070","article-title":"Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0075","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Clark","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cancergen.2016.04.058","article-title":"ATRX driver mutation in a composite malignant pheochromocytoma","volume":"209","author":"Comino-M\u00e9ndez","year":"2016","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-genom-082509-141536","article-title":"Profiling the cancer genome","volume":"11","author":"Cowin","year":"2010","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0095","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","author":"Crona","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1530\/EC-13-0009","article-title":"Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma","volume":"2","author":"Crona","year":"2013","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0105","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1158\/1078-0432.CCR-14-2854","article-title":"Spatio temporal heterogeneity characterizes the genetic landscape of pheochromocytoma and defines early events in tumorigenesis","volume":"21","author":"Crona","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0110","doi-asserted-by":"crossref","first-page":"e0133210","DOI":"10.1371\/journal.pone.0133210","article-title":"Bioinformatic challenges in clinical diagnostic application of targeted next generation sequencing: experience from pheochromocytoma","volume":"10","author":"Crona","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0115","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1158\/0008-5472.CAN-05-1427","article-title":"Novel pheochromocytoma susceptibility loci identified by integrativegenomics","volume":"65","author":"Dahia","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/35088588","article-title":"Quality control in molecular genetic testing","volume":"2","author":"Dequeker","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-017-0644-5","article-title":"Liquid biopsy: a step forward towards precision medicine in urologic malignancies","volume":"16","author":"Di Meo","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0130","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","article-title":"DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers","volume":"21","author":"de Cubas","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.molonc.2016.01.007","article-title":"Circulating tumor cell technologies","volume":"10","author":"Ferreira","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0145","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4503","article-title":"The genomic landscape of phaeochromocytoma","volume":"236","author":"Flynn","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0155","first-page":"576","article-title":"Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity","volume":"22","author":"Gill","year":"2014","journal-title":"Obesity(Silver Spring)"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jmoldx.2012.11.006","article-title":"Targeted, high-depth, next-generation sequencingof cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspirationtumor specimens","volume":"15","author":"Hadd","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.5858\/arpa.2012-0463-RA","article-title":"Fundamentals of pyrosequencing","volume":"137","author":"Harrington","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"Juhlin","year":"2015","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JCO.2012.44.2905","article-title":"Circulating tumor cells as prognostic markers in neuroendocrine tumors","volume":"31","author":"Khan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0185","first-page":"105","article-title":"Update on paragangliomas and pheochromocytomas","volume":"31","author":"Lam","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0190","article-title":"Updated on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endo Pathol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0195","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0200","doi-asserted-by":"crossref","first-page":"251364","DOI":"10.1155\/2012\/251364","article-title":"Comparison of next-generation sequencing systems","volume":"2012","author":"Liu","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0205","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-014-0288-8","article-title":"Next generation sequencing and the future of geneticdiagnosis","volume":"11","author":"Lohmann","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0210","doi-asserted-by":"crossref","first-page":"138573","DOI":"10.1155\/2015\/138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-anchem-062012-092628","article-title":"Next-generation sequencing platforms","volume":"6","author":"Mardis","year":"2013","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0220","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.seminhematol.2014.08.003","article-title":"Sequencing the AML genome, transcriptome, and epigenome","volume":"51","author":"Mardis","year":"2014","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome sequencing in microfabricated high-density picolitre reactors","volume":"43","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1073\/pnas.74.2.560","article-title":"A new method for sequencing DNA","volume":"74","author":"Maxam","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cen.12331","article-title":"Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas","volume":"80","author":"McInerney-Leo","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0240","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrg2841","article-title":"Advances in understanding cancer genomes through second-generation sequencing","volume":"11","author":"Meyerson","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11568-011-9156-3","article-title":"Review of massively parallel DNAsequencing technologies","volume":"5","author":"Moorthie","year":"2011","journal-title":"Hugo J."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2302\/kjm.54.15","article-title":"New genetic causes of pheochromocytoma: current concepts and the clinical relevance","volume":"54","author":"Neumann","year":"2005","journal-title":"Keio J. Med."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.21873\/cgp.20029","article-title":"Next-generation sequencing (NGS) analysis on single CirculatingTumor cells (CTCs) with No need of whole-genome amplification (WGA)","volume":"14","author":"Palmirotta","year":"2017","journal-title":"Cancer Genom. Proteomics"},{"issue":"97","key":"10.1016\/j.critrevonc.2017.05.005_bib0260","article-title":"A comparative analysis of exome capture","volume":"12","author":"Parla","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yexmp.2016.12.007","article-title":"Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma\/paraganglioma: a clinicopathological correlations","volume":"102","author":"Pillai","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","article-title":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","volume":"100","author":"Pillai","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0275","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2164-13-341","article-title":"A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers","volume":"13","author":"Quail","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/jhg.2013.114","article-title":"The promise of whole-exome sequencing in medical genetics","volume":"59","author":"Rabbani","year":"2014","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0285","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1210\/jc.2013-1319","article-title":"A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma","volume":"98","author":"Rattenberry","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0290","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1940-6207.CAPR-11-0432","article-title":"Key principles and clinical applications of next-generation DNA sequencing","volume":"5","author":"Rizzo","year":"2012","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0295","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt1485","article-title":"The development and impact of 454 sequencing","volume":"26","author":"Rothberg","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0300","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddq416","article-title":"A window into third-generation sequencing","volume":"19","author":"Schadt","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0310","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.2147\/OTT.S99807","article-title":"Next-generation sequencing: advances and applications in cancer diagnosis","volume":"9","author":"Serrat\u00ec","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aaf2403","article-title":"Visualization and analysis of gene expression in tissue sections by spatial transcriptomics","volume":"353","author":"St\u00e5hl","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/erm.11.3","article-title":"Next-generation sequencing and its applications in molecular diagnostics","volume":"11","author":"Su","year":"2011","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0325","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MED.0000000000000150","article-title":"Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromes","volume":"22","author":"Toledo","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/ERC-13-0101","article-title":"In vivo and in vitro oncogenic effects ofHIF2A mutations in pheochromocytomas and paragangliomas","volume":"20","author":"Toledo","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0335","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0340","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0345","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrg3117","article-title":"Repetitive DNA and next-generation sequencing: computational challenges and solutions","volume":"13","author":"Treangen","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ejhg.2013.46","article-title":"Whole-genome sequencing in health care Recommendations of the European Society of Human Genetics","volume":"21","author":"van El","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15592294.2016.1273308","article-title":"Mutual regulation of microRNAs and DNA methylation inhuman cancers","volume":"12","author":"Wang","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0360","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targetednext-generation sequencing of susceptibility genes in pheochromocytoma andparaganglioma","volume":"99","author":"Welander","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0365","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/ijc.29957","article-title":"Malignant pheochromocytomas\/paragangliomas harbormutations in transport and cell adhesion genes","volume":"138","author":"Wilz\u00e9n","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2017.05.005_bib0370","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/mgg3.210","article-title":"A novel approach for next-generation sequencing of circulating tumor cells","volume":"4","author":"Yee","year":"2016","journal-title":"Mol. Genet. Genomic Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:53:38Z","timestamp":1569344018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817300665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":74,"alternative-id":["S1040842817300665"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.05.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}